Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K). (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s163. https://doi.org/10.25251/skin.7.supp.163